Pathogen free conditions slow the onset of neurodegeneration in a mouse model of nerve growth factor deprivation

Journal of Alzheimer's Disease

Volumn 31, Issue 1, 2012, Pages 1-6

  Capsoni, Simona ^a   Carucci, Nicola Maria ^a   Cattaneo, Antonino ^a,b  

^a SCUOLA NORMALE SUPERIORE   (Italy)

^b EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

Author keywords

Amyloid ; deprivation; interleukin 6; microglia; murine pathogen free; nerve growth factor; phosphorylated tau; systemic inflammation

Indexed keywords

NERVE GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL HUSBANDRY; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MICROENVIRONMENT; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 84863895433     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120427     Document Type: Article

References (28)

1. Perry VH (2010) Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol 120, 277-286.
2. Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM (2005) Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neu-rosci 25, 8843-8853. (Pubitemid 41384452)
3. Sheng JG, Bora SH, Xu G, Borchelt DR, Price DL, Koliatsos VE (2003) Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol Dis 14, 133-145. (Pubitemid 37103187)
4. Sy M, Kitazawa M, Medeiros R, Whitman L, Cheng D, Lane TE, Laferla FM (2011) Inflammation induced by infection potentiates tau pathological features in transgenic mice. Am J Pathol 178, 2811-2822.
5. Capsoni S, Brandi R, Arisi I, D'Onofrio M, Cattaneo A (2011) A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model. CNS Neurol Disord Drug Targets 10, 635-647.
6. D'Onofrio M, Arisi I, Brandi R, Di Mambro A, Felsani A, Capsoni S, Cattaneo A (2011) Early inflammation and immune response mRNAs in the brain of AD11 anti-NGF mice. Neurobiol Aging 32, 1007-1022.
7. Ruberti F, Capsoni S, Comparini A, Di Daniel E, Franzot J, Gonfloni S, Rossi G, Berardi N, Cattaneo A (2000) Phe-notypic knockout of nerve growth factor in adult transgenic mice reveals severe deficitsin basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy. J Neurosci 20, 2589-2601. (Pubitemid 30220346)
8. Capsoni S, Giannotta S, Cattaneo A (2002) Nerve growth factor and galantamine ameliorate early signs of neurodegen-eration in anti-nerve growth factor mice. Proc Natl Acad Sci USA 99, 12432-12437.
9. De Rosa R, Garcia AA, Braschi C, Capsoni S, Maffei L, Berardi N, Cattaneo A (2005) Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc Natl Acad Sci USA 102, 3811-3816. (Pubitemid 40360709)
10. Capsoni S, Tiveron C, Amato G, Vignone D, Cattaneo A (2010) Peripheral neutralization of nerve growth factor induces immunosympathectomy and central neurodegener-ation in transgenic mice. J Alzheimers Dis 20, 527-546.
11. Gluckman PD, Hanson MA, Pinal C (2005) The developmental origins of adult disease. Matern Child Nutr 1, 130-141. (Pubitemid 41702541)
12. Godbout JP, Chen J, Abraham J, Richwine AF, Berg BM, Kel-ley KW, Johnson RW (2005) Exaggerated neuroinflammation and sickness behavior inaged mice following activation ofthe peripheral innate immune system. FASEB J 19, 1329-1331. (Pubitemid 41113739)
13. Palin K, Cunningham C, Forse P, Perry VH, Platt N (2008) Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration. Neurobiol Dis 30, 19-29.
14. McColl BW, Rothwell NJ, Allan SM (2007) Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1-and neutrophil-dependent mechanisms. J Neurosci 27, 4403-4412. (Pubitemid 46640725)
15. Nguyen MD, D'Aigle T, Gowing G, Julien JP, Rivest S (2004) Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. J Neurosci 24, 1340-1349. (Pubitemid 38222984)
16. Cunningham C, Wilcockson DC, Campion S, Lunnon K, Perry VH (2005) Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neu-ronal death during chronic neurodegeneration. J Neurosci 25, 9275-9284. (Pubitemid 41500836)
17. Inoue S, Ohta M, Li Z, Zhao G, Takaoka Y, Sakashita N, Miyakawa K, Takada K, Tei H, Suzuki M, Masuoka M, Sakaki Y, Takahashi K, Yamamura K (2008) Specific pathogen free conditions prevent transthyretin amyloidosis in mouse models. Transgenic Res 17, 817-826.
18. Capsoni S, Ugolini G, Comparini A, Ruberti F, Berardi N, Cattaneo A (2000) Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc Natl Acad Sci USA 97, 6826-6831. (Pubitemid 30412799)
19. vanGool WA, van de Beek D, Eikelenboom P (2010) Systemic infection and delirium: When cytokines and acetylcholine collide. Lancet 375, 773-775.
20. Lunnon K, Teeling JL, Tutt AL, Cragg MS, Glennie MJ, Perry VH (2011) Systemic inflammation modulates Fc receptor expression on microglia during chronic neurodegeneration. J Immunol 186, 7215-7224.
21. Levi-Montalcini R, Skaper SD, Dal Toso R, Petrelli L, Leon A (1996) Nerve growth factor: From neurotrophin to neurokine. Trends Neurosci 19, 514-520. (Pubitemid 26359871)
22. Urosevic N, Martins RN (2008) Infection and Alzheimer's disease: The APOE epsilon4 connection and lipid metabolism. J Alzheimers Dis 13, 421-435. (Pubitemid 352039025)
23. Honjo K, van Reekum R, Verhoeff NP (2009) Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease? Alzheimers Dement 5, 348-360.
24. Kountouras J, Tsolaki M, Gavalas E, Boziki M, Zavos C, Karatzoglou P, Chatzopoulos D, Venizelos I (2006) Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology 66, 938-940. (Pubitemid 43739779)
25. Kountouras J, Boziki M, Gavalas E, Zavos C, Deretzi G, Chatzigeorgiou S, Katsinelos P, Grigoriadis N, Giartza-Taxidou E, Venizelos I (2010) Five-year survival after Helicobacter pylori eradication in Alzheimer disease patients. Cogn Behav Neurol 23, 199-204.
26. Dantzer R (2004) Cytokine-induced sickness behaviour: A neuroimmune response to activation of innate immunity. Eur J Pharmacol 500, 399-411. (Pubitemid 39304023)
27. Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruiten-berg A, van Swieten JC, Stijnen T, Hofman A, Witteman JC, Breteler MM (2004) Inflammatory proteins in plasma and the risk of dementia: The rotterdam study. Arch Neurol 61, 668-672. (Pubitemid 38637682)
28. Tilvis RS, Kahonen-Vare MH, Jolkkonen J, Valvanne J, Pitkala KH, Strandberg TE (2004) Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol A Biol Sci Med Sci 59, 268-274. (Pubitemid 38375341)